Research Study

A Prospective, Multi-Institutional, Randomized, Phase II Trial of Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) of the Primary Tumor in Metastatic (M1) Prostate Cancer (PC)
Principal Investigator 
Martin Gleave

Overview

Body Locations and Systems 
Prostate Cancer
ClinicalTrials.gov# 
NCT01751438
Status 
Recruiting
Study Start/End 
Feb 27, 2015 to Dec 31, 2019
Locations 
Diamond Health Care Centre
Name/Title 
Maureen Palmer, Study Nurse
Phone 
604-875-5675
Purpose of Study 

The goal of this clinical research study is to learn if treatment with standard systemic therapy in combination with surgery or radiation therapy is more effective at controlling prostate cancer than standard systemic therapy alone. The safety of this treatment combination will also be studied.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.